Lamisil - Terbinafine
4 customer reviewsLamisil is an antifungal medicine containing terbinafine. It is for adults who need systemic treatment for widespread, recurring, or nail-related fungal infections. It works by blocking fungal cell-membrane production to kill susceptible fungi.
What is it?
Lamisil is an antifungal medicine with terbinafine as the active ingredient. In day-to-day practice, it’s most often chosen when a fungal infection is widespread, keeps recurring, or involves thicker skin areas where topicals struggle.
Composition
Active substance: terbinafine (as terbinafine hydrochloride) in film-coated tablets, typically 250 mg per tablet. Excipients commonly include tablet fillers and binders (e.g., cellulose derivatives, starches), disintegrants, and a film-coating system; exact excipients vary by manufacturer/market.
How to use?
For Lamisil tablets, the standard adult dose used in clinical protocols is terbinafine 250 mg once daily. It can be taken with or without food, and taking it at a consistent time helps adherence.
Course length depends on the site:
- Skin infections: often measured in weeks
- Nail infections: often measured in months, because nails grow slowly and the damaged portion must grow out
Missed dose guidance is simple: take the missed dose when you remember on the same day, then continue your usual schedule the next day. Do not take a double dose.
Doctor Perspectives from Clinical Practice
Doctors tend to choose Lamisil tablets when they want strong dermatophyte cover and predictable tissue penetration in keratin-rich areas like nails. Many clinicians also like that terbinafine is a single daily dose, which improves adherence compared with multi-dose regimens.
A trade-off is monitoring. Oral terbinafine is processed by the liver, so prescribers often check baseline risk factors for liver disease and review other medicines to reduce interaction risk. When patients report unusual fatigue, dark urine, or yellowing of the eyes during therapy, clinicians treat it as urgent and stop therapy until liver injury is ruled out.
How does it work?
- Route: oral (tablet)
- Adults dose: 250 mg once daily
- Adolescents ≥12 years (where indicated): 250 mg once daily
- Timing with food: take with or without food; take at the same time each day
- Skin infections (tinea corporis/cruris/pedis): 250 mg once daily for 2–6 weeks (commonly 2–4 weeks; tinea pedis may need 2–6 weeks)
- Nail infection (onychomycosis): 250 mg once daily for 6 weeks (fingernails) or 12 weeks (toenails); clinical nail clearing may continue for months after finishing
Indications
Lamisil is used for fungal skin infections caused mainly by dermatophytes. These are the organisms behind common problems like ringworm and jock itch, and they can also drive athlete’s foot in people with chronic sweating or occlusive footwear.
Typical fungal problems where terbinafine is used include:
- Ringworm (tinea corporis): circular, scaly patches with itch
- Jock itch (tinea cruris): itchy rash in the groin folds
- Athlete’s foot (tinea pedis): scaling, fissures, burning between toes or on soles
- Other fungal skin infections: including some yeast-related rashes when terbinafine is appropriate
- Nail infections: oral terbinafine is a standard option for onychomycosis in adults [1]
One limitation matters. Lamisil tablets are aimed at infections where an oral antifungal is justified; for small, mild rashes, clinicians often start with topical therapy first.
Comparison
Lamisil is a topical antifungal medicine in its cream form, yet for this product page the focus is oral terbinafine tablets, which are commonly selected when systemic therapy is needed. For skin-limited disease, topical antifungals can be enough; for nail disease, systemic therapy often wins on outcomes.
| Option (mechanism) | Best fit | Key limitations |
|---|---|---|
| Lamisil (terbinafine) | Dermatophyte-driven ringworm, jock itch, athlete’s foot; nail infections needing systemic therapy | Liver-related precautions; interaction review helps |
| Azole antifungals (e.g., clotrimazole/fluconazole class) | Broader yeast coverage; certain mixed infections depending on site | Some forms have more interactions; resistance patterns vary |
| Allylamine topical antifungal medicine (terbinafine cream category) | Localised fungal skin infections when topical therapy is appropriate | Limited penetration for nail plate infections |
Clinically, terbinafine is often preferred for dermatophyte nail infections, while azoles may be selected when yeast is suspected or confirmed. For many rashes, identifying the organism (or at least the pattern) is what determines the best antifungal, not brand preference.
Contraindications
- Hypersensitivity to terbinafine or any component of the tablet
- Severe liver disease, history of drug-induced liver injury, or unexplained abnormal liver tests
- Severe kidney disease with significantly reduced clearance
- Pregnancy (especially early pregnancy) unless specialist decision that benefits outweigh risks
- Breastfeeding (terbinafine can pass into breast milk)
- Concomitant medicines requiring interaction review due to terbinafine’s liver-enzyme effects, including:
- CYP2D6 substrates (some antidepressants, some beta-blockers)
- Warfarin (may alter bleeding risk; INR monitoring may be needed)
- Amiodarone or cimetidine (can raise terbinafine levels)
- Rifampicin (can lower terbinafine levels and reduce effect)
- Children under 12 (tablet treatment) due to limited safety data
Not recommended for
Lamisil tablets are a poor fit for some people. Avoid Lamisil or use it only under direct medical supervision if any of the following apply:
- Allergy to terbinafine or to any component of the tablet
- Severe liver disease, past drug-induced liver injury, or unexplained abnormal liver tests
- Severe kidney disease, where clearance is significantly reduced
- Pregnancy, especially early pregnancy, unless a specialist decides benefits outweigh risks
- Breastfeeding, since terbinafine can pass into breast milk
- Children under 12 for tablet treatment, due to limited safety data in this age group
Interactions to Think About Before Starting
Terbinafine can affect (and be affected by) other medicines processed by liver enzymes. In clinical practice, the interactions that most often prompt a medication review include:
- Some antidepressants (CYP2D6 substrates like tricyclics and some SSRIs)
- Some beta-blockers (CYP2D6 substrates)
- Warfarin (bleeding risk can change; closer INR follow-up may be needed)
- Amiodarone or cimetidine (can raise terbinafine levels)
- Rifampicin (can lower terbinafine levels and reduce effect)
Side effects
Serious reactions are uncommon but important:
- Liver injury: can present with jaundice, dark urine, pale stools, persistent nausea, or marked fatigue
- Severe allergic reactions: swelling of the face/lips, widespread hives, breathing difficulty
- Severe skin reactions: blistering or extensive peeling rashes require urgent assessment
The EMA highlights hepatic adverse reactions as a key risk with systemic terbinafine, which is why clinicians take liver history seriously and treat warning symptoms as urgent. [3]
Common mistakes
Small mistakes can add weeks of frustration.
- Starting tablets without confirming it’s fungal: eczema and psoriasis can mimic ringworm; treating the wrong condition wastes time.
- Expecting nails to look normal quickly: with nail infections, visible improvement follows nail growth, not the first week of therapy.
- Skipping doses on weekends: terbinafine works best with steady exposure; stop-start dosing is a pattern doctors see in “treatment failures.”
- Reinfecting from footwear: old shoes, shared bathroom floors, and unwashed socks can keep seeding athlete’s foot.
- Ignoring new symptoms: taste changes, persistent nausea, or unexplained itching can be early signals to reassess tolerability.
Doctor opinions
Doctors tend to choose Lamisil tablets when they want strong dermatophyte cover and predictable tissue penetration in keratin-rich areas like nails. Many clinicians also like that terbinafine is a single daily dose, which improves adherence compared with multi-dose regimens.
A trade-off is monitoring. Oral terbinafine is processed by the liver, so prescribers often check baseline risk factors for liver disease and review other medicines to reduce interaction risk. When patients report unusual fatigue, dark urine, or yellowing of the eyes during therapy, clinicians treat it as urgent and stop therapy until liver injury is ruled out.
Frequently asked questions
For skin infections like ringworm or jock itch, symptom relief often starts within the first week, with clearer skin over the following weeks if the fungus is the true cause. Nail infections move more slowly because nails grow slowly, so visible improvement can lag behind eradication. The NICE guidance summarises this clinical reality for systemic terbinafine: treatment duration depends heavily on infection site and nail growth rate. [4]
Yes, terbinafine is active against dermatophytes that commonly cause athlete’s foot, and it’s used both topically and orally depending on severity. Tablets tend to be reserved for extensive, recurrent, or complicated cases, or when there is associated nail infection. Good foot hygiene and reducing moisture in footwear lowers relapse risk, which WHO also emphasises in fungal skin infection prevention guidance.
Systemic terbinafine is usually avoided in pregnancy unless a clinician decides the benefit outweighs risk, especially early pregnancy. During breastfeeding, terbinafine can pass into breast milk, so many prescribers avoid oral therapy and consider alternatives. MOHAP-aligned clinical practice in the UAE prioritises minimising fetal and infant exposure when safer options exist. [5]
For tablets, use in younger children is more restricted than in adults because dosing, safety, and indications differ by age and weight. Many clinical protocols avoid terbinafine tablets under 12 years unless a specialist is involved. If a child has a suspected fungal rash, confirming diagnosis matters because eczema is a common look-alike. EMA safety summaries support age-appropriate selection and dosing.
Stop and seek urgent assessment if you develop yellowing of the eyes/skin, dark urine, pale stools, severe fatigue, or persistent nausea, since these can signal liver injury. Also treat face swelling, breathing difficulty, or widespread blistering rash as emergencies. These warnings are consistent with EMA safety information for systemic terbinafine.
It can. Terbinafine affects liver enzymes (especially CYP2D6), so it can change levels of certain antidepressants, beta-blockers, and other drugs, and some medicines can change terbinafine levels. A medication review is a normal step before starting, and it is especially important if you use warfarin or have a history of rhythm problems. Interaction guidance is covered in regulator-reviewed product information and pharmacovigilance summaries used by the EMA.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Lamisil — Comparison with alternatives
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2026). Terbinafine: Summary of Product Characteristics (systemic use). ↑
- World Health Organization (WHO) (2026). Guidance on the management of common fungal skin infections and essential antifungal medicines. ↑
- European Medicines Agency (EMA) (2026). Terbinafine: safety information and pharmacovigilance summary. ↑
- National Institute for Health and Care Excellence (NICE) (2025). Fungal nail infection (onychomycosis): management and treatment options. ↑
- MOHAP (Ministry of Health and Prevention) (2026). UAE clinical guidance: antimicrobial and antifungal stewardship considerations in community practice. ↑